DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/x2rhjj/france) has announced the addition of the "France Schizophrenia Market Highlights - 2014" report to their offering.
The latest research, 'France Schizophrenia Market Highlights - 2014', provides France schizophrenia market analysis, competitive landscape, and schizophrenia drug sales forecast in France.
The research includes France schizophrenia market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.
This research helps executives track competitor drugs sales and market share in France schizophrenia market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the France schizophrenia market.
Highlights of the Research:
Key Topics Covered:
1. Schizophrenia - Disease Definition
2. Marketed Schizophrenia Drugs in France
3. France Schizophrenia Market Analysis
3a. France Schizophrenia Market Size
3b. Drugs Sales in France Schizophrenia Market
4. Competitive Landscape in France Schizophrenia Market
4a. Drugs Market Share in France Schizophrenia Market
4b. Generics Market Share in France Schizophrenia Market
4c. Schizophrenia Phase 3 Clinical Trial Pipeline Molecules
5. France Schizophrenia Market - Future Market Outlook
5a. France Schizophrenia Market Size Forecast
5b. Drug Sales Forecast in France Schizophrenia Market
5c. Drugs Market Share in France Schizophrenia Market
For more information visit http://www.researchandmarkets.com/research/x2rhjj/france
Source: Research and Markets